Ghent University Academic Bibliography

Advanced

Fish hydrolysates : a regulatory perspective of bioactive peptides

Bert Gevaert, Lieselotte Veryser, Frederick Verbeke UGent, Evelien Wynendaele UGent and Bart De Spiegeleer UGent (2016) PROTEIN AND PEPTIDE LETTERS. 23(12). p.1052-1060
abstract
For the first time introduced on the Japanese market, bioactive fish hydrolysates are now available all over the world as food supplements, functional food ingredients or nutricosmeceuticals. They are generally produced from low value fish waste, an almost inexhaustible source of raw material, and are sold as high value products, making them economically interesting from a manufacturer's view point. Most of these products have health or structure/function claims on their packages with different actions like antihypertensive, blood-glucose lowering, anxiolytic, and skin anti-aging activities. Although the different regional legislations all aim to assure consumer safety and prevent misleading of the consumer, the number of legally approved fish hydrolysate containing products drastically differs among different regions. This is because products that have been positively evaluated based on safety and efficacy in one region were found to have not enough evidence for efficacy in another region. These findings call for further international harmonization of the regulation and classification of these products. Moreover, interaction studies of these bioactive products with the normal diet or medicines are generally not performed, keeping the consumer uninformed of the possible risks of combining these products with medicinal products or other food ingredients.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
Bioactive marine peptides, fish hydrolysates, legal classification, regulatory affairs, HEALTH CLAIMS, HYPERTENSIVE SUBJECTS, DIETARY-SUPPLEMENTS, BLOOD-PRESSURE, PROTEIN, FOOD, RAT, KATSUOBUSHI, CAPTOPRIL, SYSTEM
journal title
PROTEIN AND PEPTIDE LETTERS
Protein Pept. Lett.
volume
23
issue
12
pages
1052 - 1060
Web of Science type
Review
Web of Science id
000391702200003
JCR category
BIOCHEMISTRY & MOLECULAR BIOLOGY
JCR impact factor
0.964 (2016)
JCR rank
257/286 (2016)
JCR quartile
4 (2016)
ISSN
0929-8665
DOI
10.2174/0929866523666161102122637
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
8507591
handle
http://hdl.handle.net/1854/LU-8507591
date created
2017-02-05 10:18:58
date last changed
2017-11-13 08:18:08
@article{8507591,
  abstract     = {For the first time introduced on the Japanese market, bioactive fish hydrolysates are now available all over the world as food supplements, functional food ingredients or nutricosmeceuticals. They are generally produced from low value fish waste, an almost inexhaustible source of raw material, and are sold as high value products, making them economically interesting from a manufacturer's view point. Most of these products have health or structure/function claims on their packages with different actions like antihypertensive, blood-glucose lowering, anxiolytic, and skin anti-aging activities. Although the different regional legislations all aim to assure consumer safety and prevent misleading of the consumer, the number of legally approved fish hydrolysate containing products drastically differs among different regions. This is because products that have been positively evaluated based on safety and efficacy in one region were found to have not enough evidence for efficacy in another region. These findings call for further international harmonization of the regulation and classification of these products. Moreover, interaction studies of these bioactive products with the normal diet or medicines are generally not performed, keeping the consumer uninformed of the possible risks of combining these products with medicinal products or other food ingredients.},
  author       = {Gevaert, Bert and Veryser, Lieselotte and Verbeke, Frederick and Wynendaele, Evelien and De Spiegeleer, Bart},
  issn         = {0929-8665},
  journal      = {PROTEIN AND PEPTIDE LETTERS},
  keyword      = {Bioactive marine peptides,fish hydrolysates,legal classification,regulatory affairs,HEALTH CLAIMS,HYPERTENSIVE SUBJECTS,DIETARY-SUPPLEMENTS,BLOOD-PRESSURE,PROTEIN,FOOD,RAT,KATSUOBUSHI,CAPTOPRIL,SYSTEM},
  language     = {eng},
  number       = {12},
  pages        = {1052--1060},
  title        = {Fish hydrolysates : a regulatory perspective of bioactive peptides},
  url          = {http://dx.doi.org/10.2174/0929866523666161102122637},
  volume       = {23},
  year         = {2016},
}

Chicago
Gevaert, Bert, Lieselotte Veryser, Frederick Verbeke, Evelien Wynendaele, and Bart De Spiegeleer. 2016. “Fish Hydrolysates : a Regulatory Perspective of Bioactive Peptides.” Protein and Peptide Letters 23 (12): 1052–1060.
APA
Gevaert, B., Veryser, L., Verbeke, F., Wynendaele, E., & De Spiegeleer, B. (2016). Fish hydrolysates : a regulatory perspective of bioactive peptides. PROTEIN AND PEPTIDE LETTERS, 23(12), 1052–1060.
Vancouver
1.
Gevaert B, Veryser L, Verbeke F, Wynendaele E, De Spiegeleer B. Fish hydrolysates : a regulatory perspective of bioactive peptides. PROTEIN AND PEPTIDE LETTERS. 2016;23(12):1052–60.
MLA
Gevaert, Bert, Lieselotte Veryser, Frederick Verbeke, et al. “Fish Hydrolysates : a Regulatory Perspective of Bioactive Peptides.” PROTEIN AND PEPTIDE LETTERS 23.12 (2016): 1052–1060. Print.